Robert E. Sulentic, an officer and director of CBRE Group, Inc., filed a Form 144 notice of proposed sale on November 4, 2026, covering 2,250 Class A shares to be sold through Fidelity Brokerage Services LLC on the NYSE.

Key Highlights

  • Seller: Robert E. Sulentic, identified in the filing as both an officer and director of CBRE Group, Inc.
  • Shares proposed for sale: 2,250 Class A shares, with an aggregate market value of $315,967.50, according to the filing.
  • Acquisition date: The shares were acquired on September 5, 2014, through restricted stock vesting from the issuer, with compensation listed as the nature of payment.
  • Approximate date of sale: November 4, 2026, to be executed via Fidelity Brokerage Services LLC on the NYSE.
  • 10b5-1 plan: The filing indicates the date of plan adoption or giving of instruction as November 18, 2025.
  • Selling account: According to a remark in the filing, "Today's sale took place in the Sulentic Family Foundation in which Robert E. Sulentic is an authorized individual."
  • Shares outstanding: The filing lists 288,196,254 Class A shares outstanding at the time of the notice.

CBRE Group Officer and Director Proposes Sale of Class A Shares Under Rule 144

According to the Form 144 filed with the U.S. Securities and Exchange Commission, Robert E. Sulentic, serving as both an officer and director of CBRE Group, Inc. (NYSE:CBRE), proposed the sale of 2,250 Class A shares on November 4, 2026. The aggregate market value of the proposed sale was listed as $315,967.50. The shares are to be sold through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island 02917, on the New York Stock Exchange.

The filing states that the 2,250 shares were originally acquired on September 5, 2014, through a restricted stock vesting transaction from the issuer, with compensation noted as the nature of payment. The filing reports no securities sold during the past three months by the person for whose account the securities are to be sold, listing that section as "Nothing to Report."

A remark included in the filing notes that the sale is to take place within the Sulentic Family Foundation, in which Robert E. Sulentic is described as "an authorized individual." The filing also indicates that the sale is being conducted pursuant to a written trading plan or instruction under Rule 10b5-1, with a plan adoption date of November 18, 2025. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Robert E. Sulentic.

What Was Disclosed

CBRE Group officer and director Robert E. Sulentic filed a Form 144 on November 4, 2026, disclosing a proposed sale of 2,250 Class A shares valued at $315,967.50, originally acquired via restricted stock vesting in 2014, through a 10b5-1 plan adopted November 18, 2025.